Effect of a Hypocretin/Orexin Antagonist on Neurocognitive Performance

NCT01243060 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

203

Enrollment

OTHER

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: Almorexant
DRUG: Almorexant
DRUG: Zolpidem 10mg
DRUG: Placebo

Sponsor

Northern California Institute of Research and Education

Collaborators

[object Object]